
Vance Fowler MD MHS
Professor, Medicine, Duke University School of Medicine
Join to view full profile
2100 Erwin RdDurham, NC 27705
Phone+1 919-620-4467
Dr. Fowler is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalFellowship, Infectious Disease, 1996 - 1999
Duke University HospitalResidency, Internal Medicine, 1993 - 1996
University of North Carolina at Chapel Hill School of MedicineClass of 1993
Certifications & Licensure
NC State Medical License 1995 - 2026
American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- 1 citationsEscherichia coli ST131 Drives Carbapenem Use for E. coli Bloodstream Infections.Natalie A Mackow, Wanying Shao, Lizhao Ge, Lauren Komarow, Jianping Jiang
Clinical Infectious Diseases. 2026-07-23 - Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Acute Bacterial Skin and Skin Structure Infections.Jessica Howard-Anderson, Toshimitsu Hamasaki, Lizhao Ge, Deborah Collyar, Sara E Cosgrove
Open Forum Infectious Diseases. 2026-06-01 - 1 citationsInteragency Collaboration for Patient-Centered Antibacterial Drug Development.Jessica Howard-Anderson, Sarah B Doernberg, Dennis Dixon, Ramya Gopinath, Daniel Rubin
Clinical Infectious Diseases. 2025-08-06
Journal Articles
- Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcu...Helen W Boucher, G Ralph Corey, Vance G Fowler, Clinical Infectious Diseases
Other
- Epidemiology of and risk factors for Staphylococcus aureus bacteremia in childrenFowler VG, Sexton DJ, Kaplan SL
http://www.uptodate.com/contents/epidemiology-of-and-risk-factors-for-staphylococcus-aureus-bacterem
UpToDate, Wolters Kluwer Health - 2012-10-26 - Complications of Staphylococcus aureus bacteremiaFowler VG, Sexton DJ
http://www.uptodate.com/contents/complications-of-staphylococcus-aureus-bacteremia
UpToDate, Wolters Kluwer Health - 2012-10-05 - Treatment of Staphylococcus aureus bacteremia in adultsFowler VG, Sexton DJ
http://www.uptodate.com/contents/treatment-of-staphylococcus-aureus-bacteremia-in-adults
UpToDate, Wolters Kluwer Health - 2013-03-01
Press Mentions
Where Are We in the Battle Against Antibiotic-Resistant Infections?December 4th, 2025
The Free Market Is Failing Us on AntibioticsDecember 25th, 2022
DARPA ECHO Program Testing Epigenome or DNA Changes for Tracking Exposure to Threat Agents, Weapons of Mass Destruction (WMD) on BattlefieldSeptember 30th, 2021
Grant Support
- HLA Fine Mapping to Elucidate S. aureus SusceptibilityDUKE UNIVERSITY2021–2026
- Antibacterial Resistance Leadership Group (ARLG)DUKE UNIVERSITY2013–2026
- Antibacterial Resistance Leadership Group (ARLG)DUKE UNIVERSITY2013–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









